Notably, KAT8 is significantly upregulated in various malignancies, including thyroid carcinoma, glioblastoma multiforme, oral tongue squamous cell carcinoma, NSCLC, and thymic lymphoma, where it modulates cell proliferation [59]. This evidence concerns the gene KAT8 and glioblastoma.